House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government how many patients in the UK are being treated with (1) Paxlovid, and (2) Sotrovimab; and what is their strategy for the wider deployment of these antiviral treatments for COVID-19.  HL7562

Question HL7562: tabled on 31 March 2022 and due for answer by 14 April 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government how many patients in the UK are being treated with (1) Paxlovid, and (2) Sotrovimab; and what is their strategy for the wider deployment of these antiviral treatments for COVID-19.  HL7562
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer